RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,377 | +143.6% | 164,238 | +190.9% | 0.03% | +130.8% |
| Q2 2023 | $72,827 | -82.6% | 56,455 | -82.2% | 0.01% | -85.2% |
| Q1 2023 | $418,163 | +1233.5% | 316,790 | +1415.3% | 0.09% | +1157.1% |
| Q4 2022 | $31,359 | -94.0% | 20,906 | -95.3% | 0.01% | -94.6% |
| Q3 2022 | $525,000 | +226.1% | 444,719 | +212.8% | 0.13% | +97.0% |
| Q2 2022 | $161,000 | +436.7% | 142,187 | +1294.5% | 0.07% | +407.7% |
| Q1 2022 | $30,000 | -73.9% | 10,196 | -76.4% | 0.01% | -80.0% |
| Q4 2021 | $115,000 | -28.1% | 43,256 | +17.3% | 0.06% | +20.4% |
| Q2 2021 | $160,000 | – | 36,878 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |